Amgen appoints former Medtronic CEO S. Omar Ishrak to Board of Directors

AMGEN INC

S. Omar Ishrak appointed to Amgen Board effective July 29, 2021; will serve on Corporate Responsibility & Compliance and Compensation & Management Development committees.
Ishrak was CEO and Chairman of Medtronic (2011-2020) and currently chairs Intel Corporation's Board.
Board now consists of 12 directors, 11 of whom are independent.
Ishrak receives pro-rata annual retainer of $105,000 and committee retainers of $12,500, plus pro-rata restricted stock unit grant valued at $210,000.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

S. Omar Ishrak

director

AMGN · AMGEN INC

Effective: 2021-07-29
Filed: July 30, 2021, 7:59 PM ET

On July 29, 2021, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed S. Omar Ishrak as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

S. Omar Ishrak was appointed as director at AMGEN INC.

Action: appointed
Role: director

Exact text from the filing

On July 29, 2021, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed S. Omar Ishrak as a director of the Company, effective immediately.

View on SEC.gov

AMGEN INC filing history →

Source: SEC EDGAR

accession 0001193125-21-229599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.